A carregar...
What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?
In vitro and in vivo experimental data have pointed to new immunopathogenic mechanisms in primary Sjögren's syndrome (pSS). The availability of targeted treatment modalities has opened new ways to selectively target these mechanistic pathways in vivo. This has taught us that the role of proinfl...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3157640/ https://ncbi.nlm.nih.gov/pubmed/21371351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar3234 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|